ZeNix trial shows lower dose of linezolid can be used for treating highly drug resistant tuberculosis
Results from the ZeNix trial show that the BPaL combination of drugs remains effective against highly drug resistant tuberculosis (TB) with reduced dosage or duration of the linezolid part of the regimen.
ODYSSEY trial finds dolutegravir-based HIV treatment is better for babies
The anti-HIV drug dolutegravir, given in combination with other anti-HIV drugs, improves outcomes for babies and young children living with HIV, compared to standard anti-HIV treatment combinations.
UNITE4TB partnership launches
Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development
New results confirm the benefit of arthritis drugs in hospitalised patients with COVID-19
Findings published today in the Journal of the American Medical Association (JAMA), have prompted new World Health Organization (WHO) recommendations to use the drugs, tocilizumab or sarilumab, along with corticosteroids…
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Major international clinical trials answering questions of global public health significance
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes
Thanks to our fabulous Jo Whittle for running a 6-week Yoga & Wellness Programme, and thank you to all the @ICTM_UCL staff that took part! #Yoga is fantastic way to lower stress levels Made possible by a #UCLWellbeingSmallGrant from @UCL_Wellbeing and @UCLMentalHealth https://t.co/8zcPJxgR0a
RT @UCLTB: WHO highlight "key clinical trial characteristics to help advance novel TB therapies". We look forward to contributing further t…